Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-2-1
pubmed:abstractText
Monitoring therapeutic efficacy of antimalarial drugs is important because treatment failure rates are the primary basis for changing antimalarial treatment policy. An important aspect of efficacy studies is the use of PCR genotyping to distinguish recrudescent from new infections. The conclusions reached using this technique might be misleading if there is insufficient parasite diversity or a non-uniform haplotype frequency distribution in the study area. Statistical techniques can be used to overcome this problem, but only when data describing the haplotype frequency distribution are available. Therefore, assessing haplotype frequency and distribution should form an integral part of all studies investigating the therapeutic efficacy of antimalarial treatment regimes.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-10340324, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-10450422, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-11018154, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-12118712, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-12479544, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-12641400, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-12932754, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-15854233, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-16014861, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-16103584, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-16525096, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-16640626, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-16907979, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-16930256, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-17040849, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-17123973, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-17330781, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-17330782, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-17418906, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-8661002, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-9509189, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182325-9988316
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1471-4922
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
68-73
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Can estimates of antimalarial efficacy from field studies be improved?
pubmed:affiliation
Malaria Drug Resistance and Chemotherapy Laboratory, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston, Queensland 4029, Australia. michelle.gatton@qimr.edu.au
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural